Exact Sciences (NASDAQ:EXAS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Exact Sciences Stock (NASDAQ: EXAS) stock price, news, charts, stock research, profile.

Open	$59.16
Close	$59.70
Volume / Avg.	1.69M / 2.91M
Day Range	$58.28 - $60.67
52 Wk Range	40.62 - 85.71
Market Cap	$11.03B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	7.43%
Days to Cover	4.89

Recent News

Ironwood Q2 Earnings & Revenues Fall Shy of Estimates

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) reported break-even earnings for the second quarter of 2024 compared with the Zacks Consensus Estimate of earnings of 17 cents per share. The company had recorded adjusted earnings of 31 cents per share in the year-ago quarter.

Zacks

SpringWorks Q2 Earnings Beat, Ogsiveo Drives Revenues

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) incurred a loss of 54 cents per share in the second quarter of 2024, which was significantly narrower than the Zacks Consensus Estimate of a loss of $1.12. The company had reported a loss of $1.25 per share in the year-ago quarter.

Zacks

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H. Robinson Worldwide, and DoorDash.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Exact Sciences Corp.

Sector

Health Care

Industry

Biotechnology

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagn...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Exact Sciences (EXAS) stock?

You can purchase shares of Exact Sciences (NASDAQ:EXAS) through any online brokerage.

View our list of the best stock brokerages

Who are Exact Sciences (EXAS) competitors?

Other companies in Exact Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Exact Sciences (EXAS) stock?

Exact Sciences has a consensus price target of $82.24.

What is the current price for Exact Sciences (EXAS)?

The stock price for Exact Sciences (NASDAQ: EXAS) is $59.7 last updated August 23, 2024 at 4:00 PM EDT.

Does Exact Sciences (EXAS) pay a dividend?

There are no upcoming dividends for Exact Sciences.

When is Exact Sciences (NASDAQ:EXAS) reporting earnings?

Exact Sciences’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Exact Sciences (EXAS) going to split?

There is no upcoming split for Exact Sciences.

What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'